IPO day transforms director liability. Directors who sign the prospectus assume statutory and civil liability personally. Public disclosure obligations—quarterly filings, earnings guidance, regulatory updates—carry personal exposure. Stock price movements trigger shareholder claims naming them as defendants. Meanwhile, the private-company D&O insurance policy, built to protect against operational claims, fails to contemplate this exposure category.
D&O Insurance Becomes Essential at Listing
Most companies treat D&O insurance as a renewal item, something the broker handles on an annual cycle. However, IPO changes that entirely. D&O insurance becomes a placement document, sitting alongside the prospectus and underwriter agreements as a core piece of the IPO structure.
The reason is straightforward: going public creates new director liability that didn’t exist as a private company. Consequently, the D&O policy must protect against this new exposure. Otherwise, directors absorb the risk personally.
Most companies attempt to layer IPO-specific coverage onto their existing private-company policy through endorsements and side letters. Unfortunately, this approach fails because private-company wordings were never designed to contemplate securities claims. Bolt-on coverage creates gaps, sub-limits, and conflicts that expose directors exactly when they need protection most.
The Prospectus Creates Statutory and Civil Director Liability
The prospectus is the liability document of the IPO. Every statement in it carries personal exposure for the directors who sign off on its accuracy.
In Hong Kong, the Companies (WUMP) Ordinance imposes dual liability for prospectus misstatements. Section 40 establishes civil liability on directors for untrue statements in the prospectus, creating exposure to shareholder claims for losses incurred based on prospectus reliance. Section 40A further establishes criminal liability for knowingly including untrue statements.
This dual regime matters significantly because it expands exposure beyond the traditional insurance coverage model. D&O insurance typically covers civil claims. Criminal liability, by contrast, sits in a different category entirely—and most private-company policies were never drafted to include criminal defense costs.
Moreover, the prospectus exposes directors to underwriter liability. Underwriters conduct due diligence on prospectus disclosures. When that diligence identifies issues, underwriter disputes and indemnification claims follow—and those disputes often name individual directors, not just the company.
Critically, this exposure begins the moment the prospectus is filed. It doesn’t wait for closing or trading to commence. Directors face liability from filing day forward.
Post-Listing Disclosure Obligations Attach Personally
IPO liability doesn’t end with the prospectus. Instead, it accelerates.
Going public imposes continuous disclosure obligations on directors. They face personal exposure for quarterly earnings announcements, annual financial reporting, regulatory filings, and forward-looking guidance given to the market. Each disclosure carries potential liability to investors who rely on inaccurate statements.
Public disclosure liability differs fundamentally from prospectus liability. Prospectus liability is a one-time event. Public disclosure liability, by contrast, is recurring—quarterly, annually, whenever material information must be disclosed. It persists for as long as the company remains listed.
Under Hong Kong’s Securities and Futures Ordinance and the Listing Rules, directors bear responsibility for the accuracy of continuous disclosure. Failure to disclose material information creates regulatory exposure and shareholder liability. Additionally, misleading guidance in earnings calls creates reliance claims, and forward-looking statements that don’t materialize trigger securities litigation.
The cumulative effect is substantial: directors carry ongoing personal exposure for every material disclosure the company makes. This exposure class barely exists for private companies. Yet for public companies, it becomes a permanent liability category.
Securities Claims Are A New Loss Type
Private companies face operational claims: employment disputes, product liability, contract breaches, regulatory investigations. Standard commercial insurance and D&O policies built around operational risk typically cover these claims.
Public companies face securities claims—a different liability category entirely. Securities class actions are triggered by stock price movements and name directors as individual defendants. Moreover, these actions involve regulatory investigations by the SEC or equivalent authorities and carry reputational costs that far exceed the financial settlement.
Securities claims are not optional exposure for public companies. Rather, they are inevitable. A stock price decline of sufficient magnitude will trigger shareholder litigation, name directors, and force the company’s insurance to contemplate this as core exposure.
Most private-company D&O policies were not designed with securities claims in mind. Coverage language focuses on operational claims. Additionally, sub-limits apply to securities exposure, and exclusions carve out entire categories of securities liability. When the securities claim arrives, coverage gaps emerge—and directors discover they are underinsured.
Side A Cover Becomes The Single Most Important Layer
D&O insurance has three components: Side A, Side B, and Side C.
Side A covers individual directors and officers for their personal liability when the company cannot indemnify them—either because the company lacks financial capacity, because the company’s own coverage is exhausted, or because a conflict of interest prevents the company from providing indemnification.
For private companies, this distinction is largely academic. The company and board typically share aligned interests, and the company indemnifies directors as a matter of course.
For public companies, this alignment breaks down significantly. In securities litigation, the company’s interests often diverge from the board’s. The company may settle, cutting a deal that leaves directors exposed. Alternatively, the company may become insolvent, unable to fund indemnification. Or conflicts of interest may prevent the company from providing coverage.
When these situations arise, Side A becomes the only protection directors have. It covers them personally, independently of the company’s financial status or indemnification decision.
This is why Side A becomes the single most important part of the policy at IPO. It’s not ancillary—it’s essential. Directors need it to protect themselves when company and board interests split.
Finally, Side A coverage levels, attachment points, and exclusions must be carefully calibrated at placement. Underestimating Side A need ranks among the most common errors in IPO policy restructuring.
Historic Pre-IPO Acts Create Runoff Exposure
IPO liability doesn’t start at listing. Instead, it reaches backward.
Actions taken before going public face new scrutiny under securities claim standards after listing. A pre-IPO business decision that seemed reasonable in a private context can become the subject of shareholder litigation after the company goes public, based on its impact on future performance or market expectations.
Additionally, regulatory investigations reach into pre-listing conduct. Audits and SEC investigations often examine decisions made months or years before the public offering, looking for patterns or disclosure failures that should have been disclosed in the prospectus.
This backward reach creates runoff exposure. Directors need protection not just for forward-looking liability, but for the liability legacy they’re bringing to the public markets from their private-company past.
Typically, this runoff exposure requires either tail coverage (extended reporting period endorsements that continue coverage after the D&O policy ends) or runoff policies purchased specifically to cover pre-IPO acts. However, standard placement coverage may not adequately address this exposure.
Many companies overlook runoff exposure because they assume IPO coverage begins at listing and protects from listing forward. Unfortunately, this assumption is wrong. Runoff protection must be built into the policy structure.
Restructuring the Policy: Placement, Not Renewal
The timing of D&O restructuring is critical. It must happen at placement, not at renewal.
IPO placements create a window of opportunity. The IPO working group includes legal counsel, underwriters, and investment bankers all focused on disclosure and risk management. Moreover, the underwriter’s due diligence process creates a forum for reviewing insurance coverage gaps, and the prospectus itself provides an opportunity to disclose insurance arrangements and policy details to investors.
If companies defer D&O restructuring to the renewal cycle—months or a year after listing—these opportunities disappear. The IPO working group has disbanded. Underwriter leverage has evaporated. The prospectus is filed and locked.
More importantly, deferring restructuring leaves directors exposed in the months immediately after listing, when securities risk is highest. Stock volatility is pronounced around IPO. Investor expectations are freshly set by prospectus disclosures. Shareholder litigation risk is most acute in the weeks and months following public trading.
Conversely, restructuring at placement means coverage is in place before any of this exposure hits. Additionally, the D&O policy is built with IPO-specific knowledge—what the prospectus actually says, what disclosures were made, what exposure the underwriter identified.
The placement timing also affects pricing and terms. Underwriters and insurers are engaged in the IPO process, so companies can negotiate coverage as part of the broader placement transaction. Deferring to renewal means negotiating D&O coverage in isolation, without the context or leverage of the IPO itself.
Know Your D&O Coverage
Typically, companies treat D&O insurance as a back-office function. However, at IPO, it becomes a front-office issue. Directors need to know exactly what they’re protected against and what gaps remain.
Companies should take the following steps:
First, review what prospectus liability the policy actually covers—including criminal defense costs and underwriter indemnification disputes.
Next, confirm that securities claims protection is built into the core coverage, not carved out or sub-limited.
Additionally, understand Side A coverage levels and confirm they’re sufficient for worst-case scenarios where the company and board diverge.
Further, verify that runoff and tail coverage address pre-IPO acts and historic exposures.
Finally, test the vendor relationships and claims processes before an actual incident occurs.
The companies that complete this work are the ones that discover coverage gaps in time to fix them. Conversely, the companies that don’t are the ones that discover gaps when a securities claim arrives—months after the prospectus was filed.
Continuum helps companies audit their D&O policy before going public and build coverage that actually protects directors when it matters most: on listing day and in the months that follow.
The D&O policy your company has today isn’t the policy it needs on listing day.
Audit your D&O coverage before going public. Contact Continuum to review your policy structure, identify coverage gaps, and ensure directors are protected when it matters most: on listing day and in the months that follow. Contact us to discuss your IPO insurance strategy.
